83 related articles for article (PubMed ID: 23122829)
1. Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome.
Sova H; Puistola U; Morin-Papunen L; Karihtala P
Fertil Steril; 2013 Feb; 99(2):593-8. PubMed ID: 23122829
[TBL] [Abstract][Full Text] [Related]
2. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.
Kjøtrød SB; Romundstad P; von Düring V; Sunde A; Carlsen SM
Fertil Steril; 2008 Mar; 89(3):635-41. PubMed ID: 17548076
[TBL] [Abstract][Full Text] [Related]
4. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
[TBL] [Abstract][Full Text] [Related]
5. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
[TBL] [Abstract][Full Text] [Related]
6. Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study.
Lingaiah S; Morin-Papunen L; Risteli J; Tapanainen JS
Fertil Steril; 2019 Aug; 112(2):362-370. PubMed ID: 31227287
[TBL] [Abstract][Full Text] [Related]
7. Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns.
Vanky E; Carlsen SM
Fertil Steril; 2012 Feb; 97(2):509-15. PubMed ID: 22154766
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.
Trolle B; Lauszus FF; Frystyk J; Flyvbjerg A
Fertil Steril; 2010 Nov; 94(6):2234-8. PubMed ID: 20189560
[TBL] [Abstract][Full Text] [Related]
9. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.
Palomba S; Falbo A; Carrillo L; Villani MT; Orio F; Russo T; Di Cello A; Cappiello F; Capasso S; Tolino A; Colao A; Mastrantonio P; La Sala GB; Zullo F; Cittadini E;
Fertil Steril; 2011 Dec; 96(6):1384-1390.e4. PubMed ID: 21982727
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
Carlsen SM; Kjøtrød S; Vanky E; Romundstad P
Acta Obstet Gynecol Scand; 2007; 86(2):145-50. PubMed ID: 17364275
[TBL] [Abstract][Full Text] [Related]
11. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
12. The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome--a randomised, double-blind, placebo-controlled trial.
Lord J; Thomas R; Fox B; Acharya U; Wilkin T
BJOG; 2006 Jul; 113(7):817-24. PubMed ID: 16827766
[TBL] [Abstract][Full Text] [Related]
13. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study.
Kjøtrød SB; von Düring V; Carlsen SM
Hum Reprod; 2004 Jun; 19(6):1315-22. PubMed ID: 15117902
[TBL] [Abstract][Full Text] [Related]
14. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.
Bridger T; MacDonald S; Baltzer F; Rodd C
Arch Pediatr Adolesc Med; 2006 Mar; 160(3):241-6. PubMed ID: 16520442
[TBL] [Abstract][Full Text] [Related]
15. Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.
Fleming R; Harborne L; MacLaughlin DT; Ling D; Norman J; Sattar N; Seifer DB
Fertil Steril; 2005 Jan; 83(1):130-6. PubMed ID: 15652898
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
[TBL] [Abstract][Full Text] [Related]
17. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
Trolle B; Flyvbjerg A; Kesmodel U; Lauszus FF
Hum Reprod; 2007 Nov; 22(11):2967-73. PubMed ID: 17766923
[TBL] [Abstract][Full Text] [Related]
19. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.
Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH
Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429
[TBL] [Abstract][Full Text] [Related]
20. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]